drugset / Trial / NCT05911438
Accelerated Recovery for Total Knee Replacement Surgery With Preoperative Intravenous Iron Combined With Human Erythropoietin for Rapid Hematopoietic Mobilization to Prevent Postoperative Anemia
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is a randomized, placebo-controlled, multicenter research design to investigate the effectiveness and safety of a single-dose intravenous iron combined with HuEPO hematopoietic mobilization before surgery in patients undergoing unilateral total knee arthroplasty for the first time.
Timeline
- Start
- 2023-07
- Primary completion
- 2024-12
- Completion
- 2025-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ferric derisomaltose | Unknown | 1000 mg | Intravenous |
| Subject | Human erythropoietin | Protein / enzyme biologic | 36000 iu | Subcutaneous |
Indications
No indication recorded.